Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMOD for oral lichen planus
IRCT138710291559N1Phase 3Completed
- Sponsor
- Dental Research Center, Tehran University of Medical Sciences
- Start
- Mar 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of IMOD in oral lichen planus (OLP), sponsored by Dental Research Center, Tehran University of Medical Sciences. Started Mar 2008; status: completed.
02
Drugs
IMOD
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT138710291559N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138710291559N1.